Comparing the current results to its competitors, Enzo Biochem Inc reported Revenue decrease in the 3 quarter 2025 year on year by -20.19 %, despite the revenue increase by the most of its competitors of 0.81 %, recorded in the same quarter.
Enzo Biochem Inc, slower than the average decrease reported by the company's competitors of -10.95 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -10.95 %
Enzo Biochem Inc's Comment on Competition and Industry Peers
The company operates in the life science and biotechnology sectors, competing alongside pharmaceutical, chemical, and other related companies. The industry is characterized by intense competition, with many firms targeting similar technologies, applications, and markets. Several competitors are larger and possess greater resources. Key factors influencing competition include the ability to develop advanced scientific technologies, provide high-quality products at the forefront of technological innovation, timely product development and commercialization, the establishment and maintenance of intellectual property rights, and the attraction and retention of skilled personnel.
Bionexus Gene Lab Corp operates on a business model focused on genetic research and analysis. They provide services such as genetic testing, gene sequencing, and genetic counseling to individuals and institutions. By utilizing advanced technology and expertise, they aim to assist their clients in understanding genetic information for medical purposes and improved decision-making.
Illumina Inc is a leading company in the genomics sector, focusing on next-generation sequencing technologies that enhance genetic analysis. Their business model encompasses a diverse range of products, including sequencing platforms, reagents, and bioinformatics solutions, which together facilitate comprehensive genomic studies for researchers. By integrating these tools, Illumina supports advancements in fields such as oncology, drug discovery, and personalized healthcare, positioning itself at the forefront of genomic innovation.
Fortrea Holdings Inc is a company that operates through its subsidiaries in the business of software and technology services, providing innovative solutions and products to its clients. Its business model focuses on developing and delivering custom software applications, digital platforms, and consulting services to cater to the specific needs of various industries.
Bio-Rad Laboratories Inc operates as a global leader in life sciences and clinical diagnostics by focusing on the development, manufacturing, and distribution of a diverse array of products and solutions. Their business model emphasizes innovation, providing advanced tools and technologies that empower scientists and healthcare professionals to effectively analyze biological materials. By delivering high-quality solutions, Bio-Rad aims to facilitate scientific breakthroughs and enhance patient care in various healthcare settings.
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Sources:
Enzo Biochem Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Enzo Biochem Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
